Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes.
Breast Tumor Kinase (Brk/PTK6) has a relatively limited expression profile in normal tissue. Its expression is restricted to epithelial cells that are differentiating such as those in the epidermis, and Brk expression appears to be absent from proliferating cells in normal tissue. Also, there is now some evidence to suggest that Brk plays a functional role in the differentiation of the keratinocytes in the epidermis. We have, therefore, investigated the role that Brk/PTK6 plays in normal human primary keratinocytes by suppressing protein levels using RNA interference. We show that as primary human keratinocytes are induced to differentiate in vitro, Brk levels decrease. Decreasing Brk protein levels lead to an increase in the number of cells with a permeable plasma membrane, a decrease in epidermal growth factor receptor (EGFR) and a parallel increase in keratin 10 levels, but classical markers of apoptosis or terminal differentiation are not affected. We propose Brk, Keratin 10 and EGFR are co-regulated during differentiation and that manipulating Brk expression can influence the differentiation of normal primary human keratinocytes.
School of Biological Sciences, Royal Holloway, University of London, Egham, Surrey, UK.
J
J
Tupper
M R
MR
Crompton
A J
AJ
Harvey
D015153:Blotting, Western; D016923:Cell Death; D002454:Cell Differentiation; D049109:Cell Proliferation; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000166:cytology / Q000201:enzymology; D066246:ErbB Receptors / Q000032:analysis; D006801:Humans; D053550:Keratin-10 / Q000032:analysis; D015603:Keratinocytes / Q000166:cytology* / Q000201:enzymology*; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D012867:Skin / Q000196:embryology
D009363:Neoplasm Proteins; D053550:Keratin-10; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; C088375:PTK6 protein, human
Oncogene. 2003 Aug 7;22(32):5006-10
12902983
J Invest Dermatol. 1995 Jan;104(1):107-12
7798626
Oncogene. 1994 Aug;9(8):2383-90
8036022
Dev Dyn. 1994 Mar;199(3):176-88
7517223
J Cell Biol. 1994 Feb;124(4):619-26
8106557
Am J Pathol. 2009 Sep;175(3):1226-34
19661439
J Invest Dermatol. 1997 Dec;109(6):751-6
9406816
Oncogene. 1995 Jan 19;10(2):349-57
7838533
Gastroenterology. 2009 Sep;137(3):945-54
19501589
J Cell Biol. 2006 Jan 30;172(3):409-21
16449191
J Invest Dermatol. 1990 Jun;94(6 Suppl):164S-170S
2191051
Clin Cancer Res. 1999 Jul;5(7):1767-77
10430081
J Invest Dermatol. 1990 Jun;94(6):742-8
1693937
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14477-82
9405638
J Biol Chem. 2005 Jan 21;280(3):1982-91
15539407
Oncogene. 2000 Nov 16;19(48):5471-6
11114724
J Biol Chem. 2010 Aug 20;285(34):26013-21
20554524
Oral Oncol. 2004 Nov;40(10):1040-7
15509496
J Biol Chem. 2005 Sep 23;280(38):32856-65
16036919
Br J Dermatol. 2005 Aug;153(2):282-9
16086737
Mol Cell Biol. 2000 Aug;20(16):6114-26
10913193
Curr Biol. 1999 Apr 8;9(7):361-4
10209121
Cell. 1976 Dec;9(4 Pt 1):511-21
1009573
J Biol Chem. 1996 Nov 29;271(48):30956-63
8940083